ReviewDrug design, development and therapy2017

Profile of pembrolizumab in the treatment of head and neck squamous cell carcinoma: design development and place in therapy.

Sulsal Haque et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.